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Abstract
We previously described – studying transcriptional signatures of hippocampal CA3 explants – that febrile (FS) and afebrile
(NFS) forms of refractory mesial temporal lobe epilepsy constitute two distinct genomic phenotypes. That network analysis
was based on a limited number (hundreds) of differentially expressed genes (DE networks) among a large set of valid
transcripts (close to two tens of thousands). Here we developed a methodology for complex network visualization (3D) and
analysis that allows the categorization of network nodes according to distinct hierarchical levels of gene-gene connections
(node degree) and of interconnection between node neighbors (concentric node degree). Hubs are highly connected
nodes, VIPs have low node degree but connect only with hubs, and high-hubs have VIP status and high overall number of
connections. Studying the whole set of CA3 valid transcripts we: i) obtained complete transcriptional networks (CO) for FS
and NFS phenotypic groups; ii) examined how CO and DE networks are related; iii) characterized genomic and molecular
mechanisms underlying FS and NFS phenotypes, identifying potential novel targets for therapeutic interventions. We found
that: i) DE hubs and VIPs are evenly distributed inside the CO networks; ii) most DE hubs and VIPs are related to synaptic
transmission and neuronal excitability whereas most CO hubs, VIPs and high hubs are related to neuronal differentiation,
homeostasis and neuroprotection, indicating compensatory mechanisms. Complex network visualization and analysis is a
useful tool for systems biology approaches to multifactorial diseases. Network centrality observed for hubs, VIPs and high
hubs of CO networks, is consistent with the network disease model, where a group of nodes whose perturbation leads to a
disease phenotype occupies a central position in the network. Conceivably, the chance for exerting therapeutic effects
through the modulation of particular genes will be higher if these genes are highly interconnected in transcriptional
networks.
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Introduction
Epilepsy prevalence ranges from 0.5–1.0% in developed
countries to 1.4–5.7% in developing countries [1,2]. Around
30% of epileptic patients are refractory to the available
antiepileptic drugs [3] and account for 80% of epilepsy cost [4].
Mesial temporal lobe epilepsy (MTLE) is the most common cause
of drug-resistant epilepsy [4,5]. Prolonged febrile seizures in early
childhood constitute an initial precipitating injury usually associ-
ated with MTLE [6–9]. About 40% of the patients with MTLE
and a history of febrile seizures develop refractory epilepsy [10].
Surgical treatment for pharmacoresistant epilepsy has attained
good results but only a minority of patients with medically
refractory epilepsy are ever referred to epilepsy surgery – less than
1% in USA [11] – and often too late to prevent serious disabilities
[11,4]. This situation reinforces the demand for identifying
genomic mechanisms underlying refractory epilepsy that can be
targeted for novel preventive and drug-based therapeutic inter-
ventions [12–15].
The search for new drug-targets in epilepsy has been impacted
by recent advances in functional genomics and systems biology
[12–15]. Hippocampal explants obtained at epilepsy surgery
constitute a valuable material for functional genomic studies
because it is probable that epileptogenic genes and pathways
remain active in chronic disease, since focal regions of the brain
continue life-long chronically hyperexcitable [12]. Moreover,
transcriptional analyses in humans and in animal models of
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chronic epilepsy portrait the disease as a disturbed network of
gene-gene interactions [12,13,15,16]. Therefore, the study of
transcriptional networks in epileptic brain tissues could be very
helpful for multi-target drug discovery [12–16].
We previously described – studying transcriptional signatures of
hippocampal CA3 explants obtained at epilepsy surgery – that
febrile (FS) and afebrile (NFS) forms of refractory mesial temporal
lobe epilepsy (RMTLE) have different pathomechanisms and
constitute two distinct genomic phenotypes as shown by CA3
transcriptional co-expression networks [16]. Ex vivo high resolu-
tion magnetic resonance imaging (MRI) texture analysis of dentate
gyrus (DG) also differentiates FS and NFS cases [17] and
histological examination revealed that FS cases display higher
neuronal cell loss in the DG granule cell layer [16,17].
Comparative analysis of CA3 transcriptional interaction networks
revealed molecular mechanisms underlying RMTLE phenotypes
and indicated potential therapeutic targets [16]. However, this
network analysis was based on a limited number (hundreds) of
differentially expressed genes (DE networks) among a large set of
valid transcripts (close to two tens of thousands).
In transcriptional interaction networks, highly connected genes,
or hubs, hold the whole network together and are either associated
to specific cellular processes or link different biological processes,
organizing the interactome [18–21]. Complex disease genes, such
as those involved in RMTLE, usually display higher number of
connections in transcriptional networks, being called broker genes
because they connect many proteins that would not be otherwise
connected [22]. Therefore, in order to acquire a better under-
standing on the molecular mechanisms underlying RMTLE
genomic phenotypes it would important to develop methods to
study the complete set of valid transcripts in a particular disease
target tissue or cell population. The mathematical and computa-
tional tools for this task lay in the field of complex network analysis
[21,23].
Here we developed a methodology for complex network
visualization and analysis that allows the categorization of network
nodes according to distinct hierarchical levels of gene-gene
connections, or node degree, and of interconnection between
node neighbors, or concentric node degree (see Methods). We
were thus able to study the whole set of CA3 valid transcripts in
order to: i) obtain complete transcriptional networks, here called
CO networks, for FS and NFS phenotypic groups; ii) examine how
CO and DE networks are related; iii) identify genomic and
molecular mechanisms underlying FS and NFS phenotypes,
contributing for the discovery of potential targets for therapeutic
interventions.
Materials and Methods
Patients
The RMTLE patients included in this study were selected
through the CInAPCe-FAPESP Program (www.fapesp.br; www.
cinapce.org.br). This research has been approved by Hospital das
Clı´nicas da FMUSP and Hospital Albert Einstein, Sa˜o Paulo, SP,
Brazil institutional review boards under numbers 251/05 and
CAEE 0122.0.028.174.05. A written informed consent was
obtained from all patients. Refractory epilepsy cases were defined
as those who have not gained seizure control after treatment with
two or more antiepileptic drugs. All patients underwent
preoperative clinical, electrophysiological, neuropsychological
and neuroimaging evaluations. In this study we compared global
gene expression profiles of CA3 explants obtained at surgery
room from six FS and twelve NFS patients undergoing
corticoamigdalohippocampectomy. None of these patients had
mental retardation or first-degree family members with epilepsy
or febrile seizure history. Detailed descriptions of the patient’s
demographic and clinical data and of the procedures for brain
tissue collection and preservation for neuropathological (MRI
and histopathology) and genomic studies (DNA microarrays)
were published elsewhere [16].
Brain tissue specimens for gene expression and
neuropathological studies
Fresh ex-vivo explants from hippocampal CA3 of our patients
were obtained in the operating room and immediately preserved
with RNAlater (Qiagen cat. no. 76106, Valencia, CA). MRI and
histological studies were performed in all removed hippocampi for
neuropathology analysis and for confirming that the explants for
genomic studies were obtained at the proper site [16,17].
RNA extraction
Brain tissue explants from CA3 (3–4 mm3) were homogenized
with TissueRupter (Qiagen, cat. no. 9001272 Valencia, CA). Total
RNA was extracted from the homogenates with RNeasy Lipid
Tissue Kit (Qiagen cat. no. 74804, Valencia, CA) according to
manufacturer’s instructions. RNA quality was assessed on the
Agilent BioAnalyzer 2100 (Agilent, Santa Clara, CA). All samples
were stored at 280uC until used in hybridization experiments.
Microarray hybridization and gene expression analysis
In order to determine gene expression profiles, 44 K DNA
microarrrays (Whole Human Genome Microarray Kit, Agilent
Technologies, cat no. G4112F, Santa Clara, CA) were used. The
procedures for hybridization followed the protocols provided by
the manufacturers instructions (One-Color Microarray-Based
Gene Expression Analysis – Quick Amp Labeling). The images
were captured by the reader Agilent Bundle according to the
parameters recommended for bioarrays and extracted by Agilent
Feature Extraction software version 9.5.3, considering spots with
none or only one flag (i.e. low intensity, saturation, controls, etc.).
The selected transcripts were used for analysis using the R
software version 2.11.1 (R Development Core Team, 2010) and
the Lowess test for arrays normalization. We identified 15,615
valid GO annotated genes for the CA3 samples (6 FS and 12
NFS patients). By means of the TMEV software version 4.6.1
[24] we obtained 307 differentially expressed GO annotated
genes using the Significance Analysis of Microarrays (SAM)
procedure, all up-regulated in the FS group (fold $3.0). All
microarray raw data has been deposited in GEO public database
(http://www.ncbi.nlm.nih.gov/geo) a MIAME compliant data
base, under accession number GSE28674. Differential gene
expression data were validated through quantitative real-time
polymerase chain reaction [16].
Transcriptional interaction network analysis
Transcriptional interaction networks for CA3 differentially
expressed GO annotated genes (DE) and CA3 transcriptional
interaction complex networks for all valid GO annotated genes
(CO) were constructed for FS and NFS groups based on Pearsons
correlation. Pearson correlation identifies sets of genes which co-
varies (positively or negatively), thus allowing us to construct
networks by considering nodes as genes, with edges inferred if a
pair presents high absolute value of correlation. Specifically, we
define a correlation threshold that determines if edges are present
or absent in the resulting network. This is done in a way that all
nodes are connected to the major component and the network is
stable in the sense that slight changes in the threshold value do not
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significantly affect its topological structure. It is an usual approach
for constructing transcriptional interaction networks, also applied
in other widely used tools (e.g. FunNet [25]). Data analysis and
visualization (see below) were accomplished through the software
developed by two of the authors, FNS and L da FC (http://
cyvision.if.sc.usp.br/˜bant/hierarchical/), which provides both
dynamic and interactive data analysis of complex networks.
Concentric characterization of complex network
analysis. While statistical measurements based directly on the
degree present important information about the overall structure
of complex networks, they fail to describe the local features of each
node. The clustering coefficient [26] further extends the repertoire
of complex networks measurement by considering the number of
interconnections between the first neighborhoods of a node
normalized by the maximum number of possible connections
between them. However, the clustering coefficient may not be
sufficient to distinguish between small triangles and real high
clustered nodes. The node degree can be extended to consider
distinct levels of hierarchy (concentric levels) from a node and
obtain a measurement from each level [26–28].
Here we analyzed the networks by using the first neighborhood
concentric degree and the usual node degree. This property is
defined by means of concentric levels (or Rings),Rh(I), which
represent the nodes at distance h from a reference node I . The
concentric node degree,kh(I), of level is defined as the number of
connections between Rh(I) andRhz1(I). Figure 1 illustrates the
concentric levels and measurements for a network example. All
calculations were done by using the software available at http://
cyvision.if.sc.usp.br/˜bant/hierarchical/.
Hubs and VIPs. Traditionally, nodes with particularly high
number of connections – the so-called called hubs – are known to
play very important roles in most of real networks [21,23].
However, in real networks, hubs may not strongly participate in
some of the real networks dynamics. This is the case for
controllability in gene regulatory networks where hubs tend to
not become driven nodes (i.e. the network controllers) [29]. There
is another node category that may play an important role on such
networks: the VIPS, i.e. nodes presenting low node degree but
mostly connected only with hubs [30]. In some networks VIPs may
represent the highest control hierarchy in a system [20] and hubs
may be shadowy influenced by VIPs [31]. Some nodes may
present the VIP status for being connected with the majority of the
hubs in a network, and also present high overall number of
connections. Here we call these nodes high-hubs, which may play
even more important roles than hubs and VIPs.
One way to classify network nodes as VIPs, hubs or high-hubs is
by obtaining the node degree, k0, and the first level concentric
node degree, k1, projecting all node values in a k0 vs k1 graphic.
VIPs should present low k0 but high k1, while hubs present high
k0 and low k1, and high-hubs present high k0 and k1 values.
Figure 2 illustrates each of these node categories.
Because most real networks present scale-free distributions,
there is no clear definition for setting a degree threshold for which
we can classify nodes as being hubs or not [19,21]. This same is
true for objectively defining VIPs and high-hubs, since the
distribution of k1 also suffers from the problem of not presenting
a scale. Here we define hubs, VIPs and high-hubs by ranking them
according to k0 and k1, and then considering a set of those
presenting the highest values of each property.
Betweenness centrality. Betweenness centrality [26,32,33]
is a measurement of node importance which takes into account the
entire set of shortest paths between nodes and passing through a
particular node in a network. Betweenness is one of the most
important topological properties of a network: nodes with the
highest betweenness control most of the information flow in the
network [20].
Network Visualization. Insights about the overall structure
of complex networks can be obtained by projecting them into 2D
or 3D spaces. This allows us not only to visualize but also to get a
better understanding of which measurements and techniques may
provide relevant information about these structures. In addition,
inherent or calculated properties of nodes or edges can be
interactively explored, providing more information than those
obtained from statistical measurements such as moments and
densities.
Complex networks can be visualized through projections of
nodes represented as circles/balls and edges as lines/tubes
connecting the nodes. Force-directed methods can be applied for
visualization and are suitable for all kinds of networks, yielding
visually pleasing drawings [33–35]. This method works by
randomly placing the nodes over the metric space and incorpo-
rating physical forces between them, so that the structure relaxes
to a minimal energy state.
We developed a software to obtain visualizations of large
complex networks based on the Fruchterman-Reingold algorithm
(FR) [35], which is a force-directed technique based on molecular
dynamics employing both attractive and repulsive forces between
nodes [36]. Each node repels each other by Coulomb forces
resulting in a force F(r)j for each nodej [ V , additionally,
connected nodes, (i,j) [ E, interact by a deviation of Hooke’s
Law, F(a)j , as described in Equations 1 and 2:
~F(a)j~
X
(i,j) [E
a(~Ri{~Rj)
2r^ij ð1Þ
Figure 1. Concentric levels. Example of concentric levels of a
network for node A as reference (i.e. centered at node A). Each
concentric level is represented by rings Rh(A), namely R0(A)~fAg,
R1(A)~fB,C,Dg and R2(A)~fE,F ,G,H,I ,J,Kg, with concentric node
degrees k0(A)~3 and k1(A)~8.
doi:10.1371/journal.pone.0079913.g001
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Figure 2. Node categories. Networks illustrating the three proposed categories of nodes with VIPs presenting low node degree but high
concentric node degree at first level, hubs with lower concentric node degree and higher node degree, and high-hubs presenting high values of both
properties.
doi:10.1371/journal.pone.0079913.g002
Figure 3. Network projection and visualization. On left side of the figure the network is randomly placed over the desired metric space (in this
case, the 2D plane) and the forces described by equations (1) and (2) acting on each node are shown as arrows. Nodes without connection between
them (displayed as fading blue arrows) interact only by repulsive forces while connected nodes (red arrows) present both attractive and repulsive
interactions. Through the molecular dynamics simulation the system attains a lower energy state with connected nodes being close together if an
edge is present and further away otherwise, as shown on the figure’s right side. This methodology preserves the network topological structure. Final
visualization is obtained by vertex color mapping according to a property or measurements, e.g. node degree.
doi:10.1371/journal.pone.0079913.g003
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~F(r)j~
X
i [V
{b
(~Ri{~Rj)
2
r^ij ð2Þ
where ~Ri is the current position of node i and r^ij is the unit vector
connecting the pair of nodes, with a and b force constants.
By minimizing the energy of the system, one should obtain a set
of positions for each vertex in a way that the preferred Euclidian
distance between each connected pair is calculated by using
Equation 3.
d~
b
a
 1
4 ð3Þ
Here we chose to use molecular dynamics simulation (MDS)
[37] to minimize the energy of the system. Although there are
many advanced methods to discover the equilibrium states of
force-directed systems, MDS is a simple approach and allow us to
explore the network interactively, for instance by changing the
force constants a and bin real time or the even the connection
threshold (Fig. 3).
Our algorithm starts by assigning random positions – uniformly
distributed over the desired metric space – for each node. Then
the MDS equation:
d2~Ri
dt2
~~F(a)iz~F(r)i{m
d~Ri
dt
ð4Þ
is solved iteratively using the traditional Runge-Kutta [38]
method, where the third term acts as a viscosity force with
constant m to cool down the system and achieve an equilibrium
configuration. The algorithm ends when the nodes start to move
slowly because the forces are approaching null (at equilibrium
distances), thus attaining a minimal energy state. The parameters a
and b which define the magnitude of the forces also quantifies the
scale of the system (see equation 3), while m determines the time
Figure 4. Transcriptional interaction network for FS group. FS transcriptional interaction network based on Pearson’s correlation of 307
differentially expressed GO annotated genes (FS-DE). Hubs (red) and VIPs (blue) are identified by their gene symbols.
doi:10.1371/journal.pone.0079913.g004
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that the system will take to cool down. In our implementation
these parameters can be changed in real time by the user, however
we found that a~10{5, b~0:1 and m~0:01 are suitable values
for most of real networks. Further optimizations [39] were made
rendering this methodology computationally viable for large graph
analysis.
Interactome analysis
Interactome analyses were performed for selected hubs, VIPs
and high hubs in the DE and CO transcriptional networks
obtained for FS and NFS groups. These analyses were carried out
by using an in house free web tool developed by LA Lima & RD
Puga – Centro Internacional de Ensino e Pesquisa – Hospital A.C.
Camargo and the proteins annotated in MINT, HPRD and IntAct
databases (http://bioinfo.lbhc.hcancer.org.br/cgi-bin/interactom
egraph/index.cgi). Data analysis and visualization were accom-
plished through Cytoscape v 2.8.3.
Histopathology
We used the same previously described histological processing
[16,17,40] in order to study a larger series of patients: in addition
to the 18 cases (6 FS and 12 NFS) previously included in the
genomic studies we incorporated other 12 FS and 18 NFS cases,
all selected as described above. Briefly, the forty-eight formalin-
fixed sclerotic hippocampi were submitted to cryostat sectioning
and one out five coronal slices (sixty-micron thick) of the entire
hippocampus was stained with cresyl violet (Nissl). The pattern of
hippocampal sclerosis was described according to Blu¨mcke et al
[41]. Semi-quantitative assessment for granule cell loss (GCL),
granule cell dispersion (GCD) and granule cell bilamination (GCB)
was made using four hippocampal body slices. Granule cell layer
width was measured using ImageJ software (NIH, Bethesda,
Maryland, USA). Immunohistochemistry for stargazin followed
standard immunoperoxidase protocols for thick floating sections
[40].
Figure 5. Transcriptional interaction network for NFS group. NFS transcriptional interaction network based on Pearson’s correlation of 307
differentially expressed GO annotated genes (NFS-DE). Hubs (red) and VIPs (blue) genes are identified by their gene symbols.
doi:10.1371/journal.pone.0079913.g005
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Results
Transcriptional interaction networks for the 307 differentially
expressed GO annotated genes (DE networks) were constructed as
described in the previous section. Figs. 4 and 5 display the DE
networks for FS and NFS groups respectively. Nodes are depicted
in gradient color from red to blue according to decreasing node
degree values. Complete transcriptional interaction networks (CO)
for 15,615 valid GO annotated genes were constructed based on
Pearsons correlation. A link strength cut-off of 0.999 was adopted
for FS and NFS networks, yielding a total of 15,585 GO annotated
genes for the FS network and 11,233 GO annotated genes for the
NFS network. In order to visualize hubs, VIPs and high-hubs in
these two CO networks, both were displayed in 3D: videos S1 and
S2 show the CO networks for FS and NFS groups respectively. In
these videos the nodes are depicted in gradient color (red to blue)
according to decreasing node degree values.
The frequency distribution of the nodes and their links (Figs. 6A
and 7A) and the Kolmogorov-Smirnov test [42] confirms that the
networks are indeed scale-free. Concentric categorization (k0 and
k1) was used for selection of hubs, VIPs and high-hubs, thus
permitting the selection of the most connected nodes – hubs, high-
hubs – and of the nodes with highest k1 values, i.e. the VIPs. The
scatter plots of node degree versus concentric node degree level 1
for nodes of FS (Fig. 6B) and NFS (Fig. 6C) DE networks show the
hierarchical categorization of all nodes, hence identifying nodes as
hubs (high node degree) or VIPs (high concentric node degree, first
level). Table 1 lists the selected genes categorized as hubs or VIPs,
their corresponding betweenness centrality values and their
biological function. Figs. 7B and 7C show node hierarchical
categorization for FS and NFS CO networks identifying nodes as
high-hubs (high node degree and high concentric node degree,
first level) hubs and VIPs. Table 2 lists the selected genes
categorized as high-hubs, hubs or VIPs, their corresponding
betweenness centrality values and their biological function.
Transcriptional network analysis of differentially
expressed genes (DE networks)
FS-DE network. The six selected hubs in the DE network for
the FS group (FS-DE network) are genes related to excitatory
synaptic function (BSN, BRUNOL4, BAIAP2, and ADAM23) [43–
50] or to neuronal homeostasis (ABCG4 and ASPHD2) [51–53].
Three out of the six VIPs in FS-DE network – CACNG2, GNG3
and KCNH3 [54–59] – are important neuronal excitability
regulators. Another relevant VIP is MEG3, a maternally imprinted
long noncoding RNA gene involved in neuronal differentiation
[60–62], which is also a VIP in the NFS-DE network. The other
two VIPs are FRAS1, related to basement membranes function
and structure, as well as to cell adhesion [63], and FAM153B, that
codes for a hitherto uncharacterized protein. The biological
functions of these genes are summarized in Table 1.
NFS-DE network. In the NFS-DE network five out of the six
main hubs (Table 1) are related to synaptic function and
hippocampal excitability: ADAM23 [49,50] and ABCG4 [51],
Figure 6. Node distribution and categorization for differential-
ly expressed FS and NFS networks. Normalized degree distribution
log-log plot (A) for FS and NFS differentially expressed networks,
alongside their respective best fitted power law (lines), corresponding
to the function f (k)!k{c . Scatter plot (B,C) of node degree (k0) vs
concentric node degree (k1) measures of GO annotated genes obtained
in the networks for differentially expressed genes (DE). Hubs (red) and
VIPs (blue) genes are identified by their gene symbols. 240 nodes for
the FS network (B) and 246 nodes for the NFS network (C).
doi:10.1371/journal.pone.0079913.g006
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which are also hubs in FS-DE network, A2BP1 [64], AMPH1
[65,66], and AADACL1 [67,68]. The last hub, ACTA1, codes for
an actin involved in hippocampal neuronal motility regulation
[69]. Three out of the seven NFS-DE network VIPs (Table 1) –
JPH3 [70,71], C6orf154 [72,73] and CHRM3 [74] – are related to
synaptic function and neuronal excitability. The four others VIPs
– MYT1L [75,76], GPR68 [77], NEUROD6 [78,79] and MEG3
[60–62] – are mostly related to neural cell maturation and
hippocampal response to stress.
As a whole, DE networks hubs and VIPs encompass genes
related to molecular mechanisms acting mostly on synaptic
function and neuronal excitability, but also on neuronal differen-
tiation and motility, and regulation of cholesterol efflux from
neurons. All these mechanisms are altered in epilepsy and this
topic will be more extensively discussed further in the present
paper.
Complete transcriptional network analysis (CO networks)
FS-CO network. The selected genes of the complex network
for the FS group (FS-CO) encompass only high-hubs and VIPs
(Table 2). Three high-hubs – SDAD1, NTKR2 and N-PAC (aliase
GLYR1) – are respectively involved in brain-derived neurotrophic
factor (BDNF)-induced hippocampal neurite outgrowth [80,81],
BDNF modulation of seizure severity and susceptibility [82,83]
and epigenetic regulation of BDNF upon seizures [84,85]. The
other three high-hubs are: CIAPIM1, which is linked to apoptosis
inhibition [86,87]; JAK3 that is involved in the differentiation of
neural precursor cells [88] and survival of CA3 pyramidal neurons
[89]; and DST, acting on neuronal cytoskeleton organization
maintenance [90]. Three out of the six VIPs in the FS-CO play
relevant roles in neuronal differentiation and neuroprotection
(LIMD2, ALDH2 and PHF20L1) [91–96]. The fourth VIP,
OR4C46, is a G-protein activated olfactory receptor [97,98]. The
remaining two VIPs in this network, TM6SF2 and C17orf51, code
for hitherto uncharacterized proteins.
NFS-CO network. The NFS-CO network includes hubs and
VIPs, but no high-hubs. All the NFS-CO hubs – NAV2, RGS14,
SIAE, PCLO, TREML2 and ODZ3 (Table 2) – are relevant for
neuronal functions, particularly in the hippocampus [99–103] as it
will be further discussed. The three VIPs in the NFS-CO network
are associated to compensatory mechanisms, namely: MUS81,
which is involved in cell survival processes [104,105]; FARSA, a
gene related to axonal development of hippocampal neurons
[106,107]; and SACM1L, which is highly expressed in the
hippocampus and involved in astrogliogenesis [108–110].
Taken together, the hubs, high-hubs and VIPs of the CO
networks are mostly related to hippocampal neuronal functions,
acting either on normal or pathological processes (such as epilepsy)
that take place in different hippocampal structures. Complete
network analyses bring a potential contribution to understanding
neurodevelopmental alterations in epileptogenesis. This issue will
be detailed more extensively in the Discussion section.
Interactome analysis
We performed an interactome analysis in order to validate the
selected hubs, VIPs and high-hubs in DE and CO networks. Fig. 8
Figure 7. Node distribution and categorization for complete FS
and NFS networks. Normalized degree distribution log-log plot (A)
for FS and NFS complete networks, alongside their respective best
fitted power law (lines), corresponding to the function f (k)!k{c.
Scatter plot (B,C) of node degree (k0) vs concentric node degree (k1)
measures of GO annotated genes obtained in the complete transcrip-
tional interaction networks (CO). High-Hubs (green), Hubs (red) and Vips
(blue) genes are identified by their gene symbols.15,585 nodes for the
FS network (B) and 11,233 nodes for the NFS network (C).
doi:10.1371/journal.pone.0079913.g007
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(A–D) shows the interactome networks for DE and CO networks
of FS and NFS groups. In NFS-DE interactome network, a hub
ACTA1 (also hub in NFS-DE transcriptional network) codifies an
actin filament. Conversely, in FS-CO interactome network, a main
hub JAK3 (which is a high-hub in FS-CO transcriptional network)
codifies a tyrosine kinase. Because these proteins are commonly
involved in many cell process pathways, we selected nodes and
links for interactome analysis adopting the first and second
hierarchical levels centered in the DE or CO transcriptional VIPs
(links in red in Figs. 8B and 8C). A description of biological process
and/or function based on Gene Ontology database of selected
proteins is presented in Tables S1–S4.
Histopathology
GCL severity was higher (p,0.05) in FS group (Fig. 9A).
Differences between FS and NFS groups regarding mesial
temporal sclerosis types, GCD severity (Fig. 9E) and GCB
occurrence (Fig. 9F) were not statistically significant. Immunohis-
tochemistry confirmed tissue presence of stargazin (coded by the
gene CACNG2, a VIP in the FS-DE network) and quantitative
analysis revealed higher expression of this protein in FS cases
when compared to NFS group. Stargazin immunoreactivity was
observed in the soma of pyramidal cells of cornu ammonis and
subiculum, granule cells and hylar neurons of the dentate gyrus
(Fig. 9G). Neuronal processes and perisomatic staining were also
observed in principal cell layers. In FS cases immunoreactivity was
higher in CA1 (p= 0.0004), CA3 (p= 0.0007) and granule cell layer
(p= 0.0012), when compared to NFS group. A detailed analysis of
hippocampal neuropathology and immunocytochemistry findings
in this series of patients will be published elsewhere.
Discussion
In this paper we developed a methodology for: i) transcriptional
interaction network analysis of differentially expressed non-
categorized GO annotated genes; ii) global transcriptional
interaction analysis – encompassing all valid GO annotated genes
Table 1. Genes categorized as hubs or VIPs in FS and/or NFS transcriptional interaction networks for differentially expressed genes
(DE networks).
FS NFS
Gene Cata Bt Ctb Cat Bt Ct Gene function and/or product [reference]
BSN Hub 0.078 0.001 Bassoon – Speeding of vesicle reloading at excitatory synapses. [44]
ADAM23 Hub 0.108 Hub 0.029 Patterning of hippocampal neuronal morphology; interacts with the antiepileptogenic
protein LGI1 [50]
BRUNOL4 Hub 0.091 0.001 Regulation of genes related to synaptic function [47]
ASPHD2 Hub 0.054 Transmembrane protein involved in regulating neuronal motility [53]
BAIAP2 Hub 0.075 0.002 Regulation of NMDA receptor-mediated excitatory synaptic transmission, LTP, and learning
and memory behaviors [48]
ABCG4 Hub 0.055 Hub 0.119 Regulation of neuronal cholesterol efflux [51]
MEG3 VIP 0.117 VIP 0.002 Maternally imprinted long noncoding RNA [60] expressed in the pyramidal cell layer of the
hippocampus with a putative role in neuronal development/differentiation [117]
FAM153B VIP 0.016 0.000 Family with sequence similarity 153, member B
GNG3 VIP 0.014 0.001 G protein gamma 3, abundantly and widely expressed in the brain, required for GABABR
regulation of neuronal excitability; modulator of seizure susceptibility [57]
CACNG2 VIP 0.102 Codes for stargazin, a receptor regulatory protein that controls the surface and synaptic
expression of AMPA type glutamate receptors (AMPARs) [54]. An increase in stargazin
expression may be pro-epileptic [16,55]
KCNH3 VIP 0.014 Regulation of excitability in hippocampal pyramidal neurons. Alterations in this gene cause
epilepsy [59]
FRAS1 VIP 0.042 0.000 Structure and function of basement membranes; cell adhesion [63]
A2BP1 0.078 Hub 0.532 Codes for the splicing-regulator Rbfox1 and controls neuronal excitation in the mammalian
brain [64]
AMPH1 0.069 Hub 0.324 Regulation of endocytic recycling/synaptic vesicle endocytosis [65,66]
AADACL1 0.083 Hub 0.112 Brain serine hydrolase; regulates de novo formation of PAF [67] controlling hippocampal
hyperexcitability [68]
ACTA1 0.031 Hub 0.102 Actin involved in the regulation of neuronal motility [69]
JPH3 0.001 VIP 0.006 Junctophilin 3; involved in the control of hippocampal neuronal excitability [68]
MYT1L 0.000 VIP 0.005 Transcription factor involved in neurogenesis, neural cell maturation/functionality;
differentiation of dopaminergic neurons [76]
GPR68 0.000 VIP 0.004 Proton (pH) sensing G protein-coupled receptor regulating reactive astrogliosis [77]
C6orf154 0.043 VIP 0.003 Codifies a leucine rich repeat containing protein (LRR); LRRs are involved in controlling
hippocampal synaptic functions [72,73]
CHRM3 0.000 VIP 0.002 Cholinergic neuromodulation of hippocampal circuitry [74]
NEUROD6 0.001 VIP 0.003 Neuronal differentiation and stress tolerance [79]
aNode category: Hub or VIP; bBetweenness centrality measure.
doi:10.1371/journal.pone.0079913.t001
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– based on complex network 3D visualization; iii) concentric
characterization measuring and node hierarchical categorization.
This methodological approach allowed us to: i) construct
transcriptional networks for differentially expressed genes without
previous gene classification in thematic groups (a bias present in
widely used tools, as FunNet [25]); ii) construct global transcrip-
tional networks through new 3D visualization techniques which
revealed the global structure of such networks, with emphasis on
gene-gene interaction categorization and network topology.
The presented methodology was already been proved to be
useful in other knowledge fields [111], however it still novel when
analyzing transcriptional networks. The 3D interactive visualiza-
tion technique allowed us to explore the networks topology and
provided good starting points to find interesting features such as
the VIP and hub classification.
Here we used this complex network analysis methodology in
order to investigate the genomic and molecular mechanisms
underlying FS and NFS phenotypes in RTMLE. This approach
allowed the analysis of all hippocampal CA3 valid transcripts and
the disclosure of a more complete gene-gene interconnectivity
pattern in the target tissue. Complex network visualization and
analysis, with concomitant node categorization as hubs, high-hubs
or VIPs, for each phenotype is critical: in complex diseases, like
acquired epilepsy, that are determined by the interplay of genes
and environmental factors, the role of the disease-genes (brokers)
depends substantially on their gene-gene connectivity and much
less on structural gene alterations [15,21,22]. Moreover, tran-
scriptional analyses limited to differentially expressed genes do not
capture the relevance of interconnectivity based on genes that
differ less in their expression and more in their degree of
connectivity with other genes. This classification approach
presented to be even more informative than the usual way of
ranking genes, which relies on their global centrality and
immediate number of neighbors, thus revealing only information
about the extremes in the scales of the network (respectively, global
and strictly local properties).
When a gene-gene interaction network in a disease target tissue
suffers a perturbation caused by environmental factors this
perturbation triggers a succession of events. In febrile RTMLE,
for instance, the release of inflammatory mediators probably drives
coordinate changes in the functioning of hundreds of genes in the
brain [9]. This process of change is certainly not limited to
epileptogenesis but remains throughout the disease duration. In
this context, gene functioning reflects both pathogenic and
compensatory mechanisms. Correlating changes in transcriptional
complex networks with different pathophenotypes may be helpful
Table 2. Genes categorized as high-hubs, hubs or VIPs in FS and/or NFS complete transcriptional interaction networks (CO).
FS NFS
Gene Cata Bt Ctb Cat Bt Ct Gene function and/or product [reference]
CIAPIN1 Hhub 0.022 0.000 Cytokine-induced inhibitor of apoptosis; protection of hippocampal dopaminergic
neurons [90]
SDAD1 Hhub 0.02 0.000 Ribosome biogenesis [83] and hippocampal neurite outgrowth [84]
JAK3 Hhub 0.017 0.000 Non-receptor tyrosin kinase; involved in proliferation/differentiation of neural precursor
cells [91] and survival of CA3 pyramidal neurons [92]
NTRK2 Hhub 0.014 0.003 Brain-derived neurotrophic factor (BDNF) receptor; involved in epileptogenesis and in
hippocampal synaptic plasticity [85,86]
DST Hhub 0,012 0,005 Dystonin; cytoskeletal linker protein essential for maintaining neuronal cytoskeleton
organization [93]
N-PAC Hhub 0,015 0.000 Regulation of histone demethylation [133]
C17orf51 VIP 0,001 0.000 chromosome 17 open reading frame 51
LIMD2 VIP 0,001 0,001 Regulation of neural patterning and differentiation of specific axonal projections [95]
ALDH2 VIP 0,001 0.000 Protection of hippocampal neurons from oxidative stress [96]
TM6SF2 VIP 0,001 0.000 Transmembrane 6 superfamily member 2; Gene ID: 53345
PHF20L1 VIP 0,001 0.000 PHD finger; histone reader protein; mediates molecular interactions in gene transcription;
involved in neuronal differentiation [58,99]
OR4C46 VIP 0.000 0.000 Putatively involved in regulation of synaptic efficacy [100,101]
NAV2 Hub 0.230 Neurite outgrowth and axonal elongation [102]
RGS14 0.000 Hub 0.225 Interfaces hippocampal signalling and synaptic plasticity [103]
SIAE 0.000 Hub 0.121 Sialic acid acetyl esterase; sialic acid is involved in the modulation of hippocampal neural
and network excitability [104]
PCLO 0.000 Hub 0,085 Maintenance of synaptic vesicle clustering; plays a redundant role with BSN [45]
TREML2 0,004 Hub 0.076 Ligand in phagocytosis of apoptotic neuronal cells by microglia [106]
ODZ3 0,003 Hub 0.070 Regulator of neural connectivity [105]
MUS81 0.000 VIP 0.001 DNA recombination repair endonuclease [107] maintenance of ALT cell survival [108]
FARSA 0.000 VIP 0.001 tRNA phe; aminoacyl-tRNA synthetases are required for axonal development in
hippocampal motor neurons [109]
SACM1L 0.000 VIP 0.002 Highly expressed in hippocampus; shares sequence homology with synaptojanins [111]
and is involved in astrogliogenesis [113].
aNode category: High-hub (Hhub), hub or VIP; bBetweenness centrality measure.
doi:10.1371/journal.pone.0079913.t002
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Figure 8. Interactome networks. Interactome networks for DE (A, B) and CO (C, D) hubs/high-hubs (depicted in red) and VIPs (depicted in blue)
using MINT, HPRD and IntAct databases for FS (A, C) and NFS (B, D) groups. Node shapes and colors represent biological processes, as follows:
diamond for actin/cytoskeleton; hexagon for signaling (blue or pink borders stands for neurotransmission or inflammation); octagon for calcium ion
binding/transport/homeostasis; octagon with blue or pink border stand for cation channel or cation transport respectively; parallelogram for cell-cell
interaction/adhesion; rectangle for cell processes (blue or green borders stand for apoptosis or proliferation); bordered triangles stand for synaptic
transmission/SNARE complex (light blue), voltage-gated ion channel activity (pink), GABAergic synaptic transmission (red), synaptic transmission
(green) and neuronal differentiation/motility (purple); vee for cholesterol homeostasis; ellipse for other processes. Nodes in red represent high-hubs
or hubs in CO or DE transcriptional networks, respectively; Nodes in blue represent VIPs in CO and DE transcriptional networks; Node size is related to
node degree (number of links). Links in red represent the first and second hub connections, centered in DE or CO VIPs.
doi:10.1371/journal.pone.0079913.g008
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for finding novel potential therapeutic targets and design
intervention strategies.
Joint visualization and analysis of CO and DE networks
revealed that DE hubs and VIPs are evenly distributed inside
the CO networks (i.e., not as clusters), as shown in videos S1 and
S2. Nonetheless, in spite of this shared network topology, the sets
of hubs, VIPs and high-hubs of DE and CO networks have
somewhat different profiles regarding their biological functions
and/or presence in specific molecular pathways, as discussed
below.
DE networks
Considering only the genes with known biological functions in
DE networks (i.e. 20 out of 22, see Table 1), four out of the six
hubs in FS-DE network are related to synaptic transmission and
neuronal excitability, as well as three out of the five VIPs. In NFS-
DE network the situation is quite similar: four out of six hubs and
three out of five VIPs have this functional profile, totalizing 13 out
20 genes in both networks (ADAM23 and ABCG4 are common
hubs and MEG3 is a common VIP in DE networks). The
remaining hubs and VIPs with known biological function in DE
networks (Table 1) are related to: neuronal differentiation (two
genes), neuronal motility (two genes), reactive astrogliosis (one
gene), neuronal cholesterol balance (one) and cell adhesion (one).
All these genes play relevant roles in regulating neuronal functions.
Alterations in most of these genes are associated with epilepsy,
what makes them potential therapeutic targets. The following
discussion is centered in this later issue.
FS-DE networks. The first FS-DE hub to considered here,
BSN, codes for Bassoon, a cytomatrix protein that speeds vesicle
reloading at excitatory synapses [44,43]. BSN and the gene PCLO
(Piccolo), which is a hub in the CO-NFS network, exert a
redundant role in maintaining synaptic vesicle clustering [45].
Bassoon interacts with the TrkB/BDNF system in determining
cell-type-specific plasticity changes, as seen in mutant epileptic
mice lacking Bassoon [112,113], indicating an interaction between
BSN and NTKR2, a gene that codes for TrkB, the BDNF receptor,
and that is also involved in mesial temporal lobe epileptogenesis
[82,84]. NTKR2 is a high-hub in the CO-FS network, what points
out for its relevance in hippocampal CA3 molecular pathways. On
the other hand, valproic acid, a commonly used antiepileptic drug,
rebalances TrkB and BDNF brain levels in Bassoon mutant mice
and reduces epileptic seizures [113]. This underscore BSN, BDNF
and NTRK2 interconnection in epilepsy, corroborated in this study.
Two other hubs, ADAM23 and BRUNOL4, act on neuronal
excitability. ADAM23 controls dendritic arborization in CA1
pyramidal neurons and is a LG1L receptor [50]. BRUNOL4 (aliase
CELF4) codes for a RNA-binding protein and is primarily
expressed in excitatory neurons – including large pyramidal cells
in the cerebral cortex and hippocampus – and regulates excitatory
but not inhibitory neurotransmission. This gene regulates trans-
lation and local abundance of several synaptic function-associated
genes. BRUNOL4 deficiency causes complex seizure disorders in
mutant mice and humans [46,47]. Both genes play important roles
in controlling neuronal excitability. ADAM23 is an interactor of
LGI1, an important antiepileptogenic protein [49,50] and
BRUNOL4 codes for a RNA-binding protein highly expressed in
the hippocampus that regulates several genes related to synaptic
functions [47]. The LGI1/ADAM23 (ligand-receptor) complex is
considered ‘‘an exciting therapeutic target for human epilepsy’’
[50] and the same can be stated about BRUNOL4, since alterations
in this gene are involved not only in epilepsy but also in other
neurological conditions, such as autism [47].
There are also two relevant nodes common to FS-DE and NFS-
DE networks: ABCG4, a hub, and MEG-3, a VIP, both associated
to brain homeostasis and stress responses. ABCG4 controls
neuronal but not astrocytic cholesterol efflux [51]. Changes in
brain cholesterol levels during status epilepticus occurs in temporal
lobe epilepsy [52]. Disruption of brain cholesterol homeostasis
occurs in other neurological, neurodegenerative and neurodevel-
opmental disorders and suggests a potential role of ABCG4 in brain
disorders [51]. MEG3 (aliase GTL2), is a maternally imprinted long
noncoding RNA gene [60]. Long noncoding RNAs seem to play
relevant functions central nervous system development, homeo-
stasis, stress responses, and plasticity [61,62]. MEG3 orthologous
gene in mice, Gtl2, is strongly expressed in the pyramidal cell layer
of the hippocampus and this expression is consistent with a role in
neuronal development and differentiation [114].
The remaining FS-DE main hubs are BAIAP2 and ASPHD2.
The first is involved in excitatory synaptic transmission and in
neurite growth and spine morphogenesis [48] whereas the second
Figure 9. Histopathological results. Histopathological findings in sclerotic hippocampi from patients with epilepsy and semiquantitative analysis
of granule cell loss (GCL) in patients with (FS) or without (NFS) febrile seizures as initial precipitant insult. A: semiquantitative analysis of granule cell
loss (GCL) in patients with (FS) or without (NFS) febrile seizures as initial precipitant insult (*: p,0.05). B: overview of a histological slice. C: preserved
granule cell layer. D: granule cell loss. E: granule cell dispersion. F: granule cell bilamination. G: stargazin-positive cells (arrows). Calibration bars: B
4 mm; C–F 200 um; G 50 um. GCL was graded into the following categories: grade zero (no GCL), grade 1 (mild reduction of neuronal density), grade
2 (moderate reduction of neuronal density), grade 3 (severe reduction of neuronal density), and grade 4 (disruption of neuronal cell layer).
doi:10.1371/journal.pone.0079913.g009
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codes for an oxidoreductase that regulates neuronal motility driven
by transient (mild) oxidative stress [53].
The FS-DE network has three distinctive VIPs, CACNG2,
KCNH3 and GNG3, with relevant roles in epilepsy. CACNG2,
which codes for the protein stargazin, is essential for stabilizing
diffuse AMPA receptors in the post synaptic density, an important
feature of glutamatergic synaptic transmission [54,115] and
genetic absence/alteration enhances thalamic excitability and
contributes to epilepsy phenotype [55]. This gene was previously
found to be up-regulated in febrile RMTLE [16] and stargazin
overexpression in FS patients was confirmed by immunohisto-
chemistry in the present work. Stargazin and AMPA receptor
membrane targeting contribute to neuronal hyperexcitability, with
a pathophysiological role in the epilepsy phenotype [116].
Stargazin is considered a novel potential target for antiepileptic
drugs [117]. KCNH3, which codes for a potassium channel Kv7, is
a potent regulator of hippocampal and cortical excitability [58,59]
and is also a target of the endogenous antiepileptic neuropeptide
somatostatin in hippocampal pyramidal neurons [58,16]. GNG3 is
widely expressed in the brain and required for GABABR neuronal
excitability regulation. The role of GNG3 protein, and of other G-
protein subtypes, in neuronal excitability regulation is currently
being investigated in animal models: GNG3 genetic deficiency
causes increased susceptibility to seizures in mice [56,57].
NFS-DE network. This network harbors hubs and VIPs with
prominent roles in neuronal excitation, synaptic transmission and
neuronal differentiation. Two of these hubs, ADAM23 and
ABCG4, are also present in the FS-DE network and were
commented above. Three out the other four hubs are directly
involved in neuronal excitability (the exception is ACTA1,
involved in hippocampal neuronal motility regulation [118]).
Accordingly, A2BP1 codes for a RNA-binding protein, Rbfox1,
that regulates the alternative splicing of neuronal transcripts
involved in synaptic transmission and membrane excitation, some
of which involved in epilepsy [64]. The study of post-transcrip-
tional regulation by Rbfox1 is an area of interest for understanding
the control of cell homeostasis and misregulation in neurological
diseases [64]. This gene probably exerts a role similar to
BRUNOL4 in the FS-DE network, its mutation causing epilepsy
[64]. AMPH1 codes for amphiphysin I, which is an important
regulator of synaptic vesicle endocytosis [119] when massive
amounts of Ca2+ flow into presynaptic terminals, a phenomenon
observed in epilepsy [120]. AADACL1 regulates de novo formation
of platelet-activation factor (PAF), an inflammation mediator. PAF
accumulates in the brain after seizures and causes hippocampal
hyperexcitability [121]. AADACL1 attenuates hippocampal excit-
ability by reducing de novo PAF formation [122].
Three of the six NFS-DE VIPs are linked to neural excitability
and circuitry control. One of them, JPH3, codes for junctophilin 3.
Junctophilins 3 and 4 are involved in subsurface cistern formation
in hippocampal pyramidal neurons [123] and exert a pivotal role
in neural excitability fundamental to plasticity and integrated
functions [124]. The two other VIPs are involved in hippocampal
synaptic transmission and neuromodulation. CHRM3, codes for
the muscarinic acetylcholine receptor that confers differential
cholinergic modulation to neurochemically distinct hippocampal
basket cells subtypes [74]. Early life seizures increase the efficacy of
muscarinic receptors coupling to protein G accounting to adult
susceptibility to epilepsy, what makes this gene a potential target
for novel anticonvulsant drugs [16,125]. C6orf154 codes for a
leucine rich repeat containing protein (LRR). It was recently
discovered that some LRR-containing proteins, as Elfn1, are
involved in controlling hippocampal synaptic functions and,
moreover, in similar ways as perfomed by LRR containing-Trk
neurotrophin receptors and the antiepileptic protein LG1L
[72,73]. Consequently, C6orf154 is an interesting candidate for
further investigations on target-specific synaptic transmission [72].
Among the other three VIPs, two are genes acting on neuronal
differentiation and one (GPR68) is associated to astroglial cell
functions. MYT1L, it is an important gene for neurogenesis and
neural cell maturation [75], being involved in the maturation of
dopaminergic neurons [76] and NEUROD6 is a gene involved in
neuronal stress tolerance in CA1-CA3 pyramidal neurons [78,79].
NEUROD6, a gene responsible for granule cell differentiation in
the hippocampus [126], was described as not expressed in
heterotopic neurons in epilepsy-induced hippocampal heterotopia
[78]. Our patients, in FS and NFS groups, presented heterotopic
neurons in the granule cell layer and CA3 expression of
NEUROD6 was found in both groups, being significantly higher
in FS cases, as determined by quantitative real-time polymerase
chain reaction [16].
CO networks
There are 19 genes with known biological functions in CO
networks (Table 2) and 12 of these genes are involved with
hippocampal cell differentiation or neuroprotection. The other
seven genes are mostly involved with hippocampal excitability and
epileptogenesis. We shall focus here mainly on genes with relevant
roles in epilepsy- associated mechanisms.
FS-CO network. The selected nodes in this network include
just high-hubs and VIPs. High-hubs may play more important
roles than hubs and VIPs in transcriptional interaction networks
[30]. A very relevant high-hub in FS-CO network is NTRK2,
which codes for the BDNF receptor TrkB, a therapeutic target
candidate. In several MTLE animal models seizures induce a
pronounced increase of BDNF expression and enhance the
activation of TrkB in the mossy fiber pathway of hippocampus.
Transgenic overexpression of BDNF or Trkb increased seizure
susceptibility and severity, whereas diminished TrkB signaling
reduced epileptogenesis, thus indicating a causal role for BDNF
and TrkB in limbic epileptogenesis [82,87,127,128]. BDNF and
TrkB are therefore potential targets for antiepileptic and
antiepileptogenic therapies [82].
Two among the other five high-hubs, SDAD1 and N-PAC are
related to BDNF-driven processes whereas the other three –
CIAPIM1, JAK3 and DST – are associated to different compen-
satory mechanisms. Actually, SDAD1 is involved in ribosomal
biogenesis [80], a biological process that has been associated to
brain-derived neurotrophic factor (BDNF)-induced hippocampal
neurite outgrowth [60]. N-PAC (aliase GLYR1), regulates histone
demethylation [129], a catalytic-activity-based epigenetic drift
process that occurs in febrile seizure-induced epileptogenesis [84].
Interestingly, this epigenetic mechanism also regulates the
elevation of BDNF gene expression after seizures [85]. CIAPIM1,
codes for anamorsin, a cytokine-induced apoptosis inhibitor [86].
The nuclear translocation of anamorsin is a reactive oxygen
species-dependent event and regulates the transcription of several
genes involved in the protection of hippocampal dopaminergic
neurons [87]. JAK3 codes for a non-receptor tyrosin kinase and is
involved in proliferation and differentiation of neural precursor
cells [88] as well as in survival of CA3 pyramidal neurons [89].
DST, codes for dystonin, a cytoskeletal linker protein [130], and it
is essential for maintaining neuronal cytoskeleton organization.
Four out of the six FS-CO VIPs (Table 2) have known biological
functions. Three are involved with hippocampal neuronal
patterning and/or differentiation (LIMD2, PHF20L) and protec-
tion of hippocampal neurons against oxidative stress (ALDH2),
what may be related to compensatory mechanisms, as discussed
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above. The other VIP, OR4C46, codes for an olfactory receptor
(OR) and is ectopically expressed in CA3. Although functional
interpretation for ectopic OR expression based only on transcrip-
tion information must be taken with precaution [134], it is relevant
that some ORs have been implied in the regulation of synaptic
efficiency by modulating Ca2+ levels [97,98]. Moreover, it is worth
to consider that: i) several OR genes are expressed in the
hippocampus of MTLE patients [132]; ii) genes controlling
selective connectivity at dentate gyrus-CA3 and CA3-CA1
synapses map near OR clusters [133], and iii) olfactory sensory
neurons are involved with seizure causation in mice [134].
NFS-CO network. Some hubs of this network present rather
high betweenness centrality values (Table 2), what can be
considered a measure of their network essentiality and an
indicative of relevant biological roles for these hubs [20,21].
Three of these hubs probably participate in compensatory
mechanisms: NAV2 is a key player in the processes of neurite
outgrowth and axonal elongation [99]; ODZ3 codes for a teneurin,
which is a neuronal connectivity regulator [102]; and TREML2
acts on the phagocytosis of apoptotic neuronal cells by microglia
[103]. The other three hubs are linked to synaptic function and
neuronal excitability. RGS14 acts at the interface of hippocampal
signaling and synaptic plasticity [100]. SIAE codes for a sialic acid
acetyl estearase. Sialic acid modifications are involved in
hippocampal CA3 neural regulation and network excitability
[101]. PCLO (Piccolo) acts on the maintenance of synaptic vesicle
clustering [45]. PCLO acts redundantly with BSN, which is a hub in
FS-DE network, on synaptic vesicle clustering and integrity
maintenance [45,135].
Finally, the three NFS-CO VIPs may be also involved in
compensatory mechanisms: MUS81 codes for a DNA recombina-
tion repair endonuclease highly accumulated in nucleoli [104] and
is involved in the Alternative Lengthening of Telomeres (ALT)-cell
survival process [105], FARSA codes for an aminoacyl-tRNA
synthetase related to axonal development and SAMC1L is highly
expressed in hippocampus. This gene regulates Golgi membrane
morphology [108,109], shares sequence homology with synapto-
janins [108] and it is involved in astrogliogenesis [110].
Taken together, the results for DE networks reflect a majority of
processes linked to synaptic transmission and neuronal excitability,
whereas the profile of CO networks show predominance of
compensatory mechanisms for the neuronal cell loss/damage
associated with epilepsy-induced hippocampal sclerosis [136].
Compensatory mechanisms encompass dentate gyrus neurogenesis
[137], synaptic reorganization, axonal sprouting, reactive astro-
gliosis, and the generation of new excitatory synaptic connections,
that can alleviate or aggravate epilepsy [138,139].
Interactome validation and histopathology
Interactome analyses (Figs. 8 A–D) validated most of the
selected high-hubs, VIPs and hubs obtained through DE and CO
transcriptional interaction network analyses: many high-hubs and
hubs of transcriptional networks are also hubs in the interactome
networks. The DE-FS interactome showed that the majority of the
proteins are involved in synaptic transmission and neuronal
excitability, whereas the DE-NFS interactome network is more
related to neuronal differentiation processes. Both FS-CO and
NFS-CO interactome networks showed predominance of path-
ways linked to neuronal differentiation, synaptic transmission and
cell processes associated to compensatory mechanisms, although
different subsets of proteins were involved in FS or NFS pathways.
Histopathological findings confirmed that stargazin (CACNG2) is
significantly more expressed in CA1, CA3 and granule cell layer of
FS cases, what is in accordance with our genomic, transcriptional
and interactome network data and with our previous work [16].
Finally, it is worth to note that the FS patient’s group shows
significantly increased granule cell loss (Fig. 9A), probably
reflecting enhanced CA3 neuronal excitability and diminished
compensatory mechanism activity, as indicated by genomic and
interactome data.
Complex network driven-view of RMTLE
In conclusion, complex network analysis conducted in this study
yielded a broad and more detailed view of genomic and molecular
mechanisms involved in RMTLE in comparison to analyses
centered on differentially expressed genes. Specifically, hubs and
VIPs in DE networks are mostly related to neuronal excitability
and, in a broad sense, play pro-epileptic roles. Conversely, hubs,
VIPs and high-hubs in CO networks are more frequently related
to neuronal differentiation, neuroprotection and synaptic function,
in a scenario compatible with compensatory mechanisms that may
play a reparatory role, but may also be linked to epilepsy
pathogenesis [138,139]. The DE genes with higher connectivity
occupy a central position in both DE and CO networks, reflecting
their biological essentiality and role in disease [125]. The same
network centrality is observed for the hubs, VIPs and high-hubs of
CO networks, being consistent with the network disease model
[21], where a group of nodes whose perturbation leads to a disease
phenotype forms a disease module occupying a central network
position [21,140]. This finding indicates that the probability of
exerting therapeutic effects through the modulation of particular
genes will be higher if these genes are highly interconnected in
transcriptional networks [15].
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